DAFLON Trademark

Trademark Overview

On Monday, February 24, 2020, a trademark application was filed for DAFLON with the United States Patent and Trademark Office. The USPTO has given the DAFLON trademark a serial number of 79283156. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by BIOFARMA. The DAFLON trademark is filed in the Pharmaceutical Products category with the following description:

A proprietary medicine for the treatment of vascular and vein disorders
daflon

General Information

Serial Number79283156
Word MarkDAFLON
Filing DateMonday, February 24, 2020
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6224595
Registration DateTuesday, December 22, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesA proprietary medicine for the treatment of vascular and vein disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressF-92284 SURESNES CEDEX
FR
Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressF-92284 SURESNES CEDEX
FR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressF-92284 SURESNES CEDEX
FR

Trademark Events

Event DateEvent Description
Sunday, May 2, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 29, 2021FINAL DISPOSITION PROCESSED
Monday, March 22, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, October 24, 2020NOTIFICATION PROCESSED BY IB
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 28, 2020EXAMINER'S AMENDMENT ENTERED
Friday, August 28, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 28, 2020EXAMINERS AMENDMENT E-MAILED
Friday, August 28, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, June 29, 2020INTERNATIONAL REGISTRATION RENEWED
Monday, June 29, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 29, 2020FINAL REFUSAL E-MAILED
Monday, June 29, 2020FINAL REFUSAL WRITTEN
Wednesday, June 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 3, 2020ASSIGNED TO LIE
Friday, May 29, 2020REFUSAL PROCESSED BY IB
Monday, May 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 15, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 15, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 4, 2020REFUSAL PROCESSED BY MPU
Wednesday, April 22, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 21, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 21, 2020ASSIGNED TO EXAMINER
Saturday, April 18, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, April 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 9, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

daflon vein disorders vascular treatment medicine proprietary